Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Venous Thrombosis × Intermittent Pneumatic Compression Devices × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1 Postoperative Complications 1

Interventions

Dalteparin 5 apixaban 4 bemiparin 2 abelacimab 2 Tinzaparin 2 Nadroparin 2 MAA868 2 Heparin, Low-Molecular-Weight 2 Enoxaparin 2 reviparin 1 edoxaban 1 certoparin 1 atezolizumab 1 acarboxyprothrombin 1 Warfarin 1 Rivaroxaban 1 Phenprocoumon 1 Intermittent Pneumatic Compression Devices 1 Fondaparinux 1 Dabigatran 1 Bevacizumab 1 Acenocoumarol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

University of Alabama at Birmingham

Phase 3 Terminated

7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡